Ibritumomab Tiuxetan and Targretin (Bexarotene (Systemic))
Determining the interaction of Ibritumomab Tiuxetan and Targretin (Bexarotene (Systemic)) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: bexarotene
Brand name: Targretin
Synonyms: Bexarotene, Bexarotene (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Targretin (Bexarotene (Topical))
- Ibritumomab Tiuxetan-Targretin Gel
- Ibritumomab Tiuxetan-Targretin topical
- Ibritumomab Tiuxetan-Tarina 24 Fe
- Ibritumomab Tiuxetan-Tarina Fe 1/20
- Ibritumomab Tiuxetan-Tarka
- Targretin (Bexarotene (Systemic))-Ibrutinib
- Targretin (Bexarotene (Systemic))-Ibrutinib Capsules
- Targretin (Bexarotene (Systemic))-Ibrutinib Tablets
- Targretin (Bexarotene (Systemic))-Ibu
- Targretin (Bexarotene (Systemic))-IBU Tablets
- Targretin (Bexarotene (Systemic))-Ibu-2